Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT00369460
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Biopsy-proven inoperable locally advanced or metastatic pancreatic adenocarcinoma
PATIENT CHARACTERISTICS:
* ECOG performance status 0-3
* Must be able to stand unassisted on a scale
* Must not have pacemaker or implanted defibrillator
PRIOR CONCURRENT THERAPY:
* Prior chemotherapy or radiotherapy allowed
* No concurrent use of any of the following:
* Corticosteroids
* Steroids as anti-emetics associated with chemotherapy allowed
* Anabolic steroids
* Thalidomide
* Megesterol
* Eicosapentaenoic acid (EPA)
* Nutritional supplements without EPA allowed
* Juven
* Concurrent enrollment in other clinical trials allowed
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00369460
Study Brief:
Protocol Section:
NCT00369460